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Introduction: Sepsis is a major public health problem. Prior studies using hospital-based data describe higher rates
of sepsis among black than whites participants. We sought to characterize racial differences in incident sepsis in a
large cohort of adult community-dwelling adults.
Methods: We analyzed data on 29,690 participants from the Reasons for Geographic and Racial Differences in Stroke
(REGARDS) cohort. We determined the associations between race and first-infection and first-sepsis events, adjusted for par-
ticipant sociodemographics, health behaviors, chronic medical conditions and biomarkers. We also determined the associ-
ation between race and first-sepsis events limited to first-infection events. We contrasted
participant characteristics and hospital course between black and white sepsis hospitalizations.
Results: Among eligible REGARDS participants there were 12,216 (41.1 %) black and 17,474 (58.9 %) white participants.
There were 2,600 first-infection events; the incidence of first-infection events was lower for black
participants than for white participants (12.10 vs. 15.76 per 1,000 person-years; adjusted HR 0.65; 95 % CI, 0.59-0.71). There
were 1,526 first-sepsis events; the incidence of first-sepsis events was lower for black participants than for white participants
(6.93 vs. 9.10 per 1,000 person-years, adjusted HR 0.64; 95 % CI, 0.57-0.72). When limited to
first-infection events, the odds of sepsis were similar between black and white participants (adjusted OR 1.01;
95 % CI, 0.84-1.21). Among first-sepsis events, black participants were more likely to be diagnosed with severe
sepsis (76.9 % vs. 71.5 %).
Conclusion: In the REGARDS cohort, black participants were less likely than white participants to experience infection and
sepsis events. Further efforts should focus on elucidating the underlying reasons for these observations, which are in
contrast to existing literature.Introduction
Sepsis is a clinical disease characterized by a systemic
inflammatory response to a severe infection. Sepsis is an im-
portant public health problem, responsible for more than
750,000 hospitalizations, 570,000 Emergency Department
visits and 215,000 deaths annually [1]. In the United States
health system, sepsis care exceeds $16.7 billion annually [1].* Correspondence: hwang@uabmc.edu
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(http://creativecommons.org/publicdomain/zeSepsis survivors are at increased risk of long-term death,
cognitive impairment and functional limitation [1–9].
Population-based studies have shown that black
individuals have higher rates of sepsis, hospitalization mor-
tality, and are twice more likely to develop sepsis than white
individuals [3–6, 10–13]. Over a 22-year study period black
participants had higher rates of sepsis than white partici-
pants [5]. Mayr et al. found that higher incidence of sepsis
among black patients was attributed to higher infection-
related hospitalization rates and a higher risk of acute
organ dysfunction [6]. Barnato, et al. found that eventicle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in
operly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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enced a higher population-based incidence of severe
sepsis [3]. An important feature of these studies was
their use of hospital discharge data for identifying
sepsis events without information on initial clinical
presentation or comorbid conditions. Furthermore, these
studies did not distinguish hospital-acquired from
community-acquired sepsis events, nor compare hospital-
ized sepsis patients with non-hospitalized individuals.
The REasons for Geographic and Racial Differences in
Stroke (REGARDS) cohort is one of the largest longitudinal
cohorts of community-dwelling adults in the United States
[14]. The objective of this study was to characterize racial
differences in sepsis incidence in the REGARDS cohort.
Methods
Ethics and consent statement
The Institutional Review Board of the University of
Alabama at Birmingham approved this study. We obtained
informed consent from all participants of the study during
baseline visit, and we also obtained consent for subsequent
blood samples.
Study design and data source
We performed a prospective cohort analysis using
REGARDS, one of the largest ongoing national longitudinal
cohorts of community-dwelling adults in the United States
[14]. Designed to evaluate geographic and black-white
differences in risk factors for stroke, REGARDS recruited
30,239 black and white participants aged ≥45 years. The
cohort is 45 % male and 41 % African American, and 69 %
of participants are >60 years old. REGARDS recruited
participants between January 2003 and October 2007.
In 6-month intervals, REGARDS contacted the participants
by telephone to identify any hospitalizations experienced by
the participant. REGARDS personnel retrieved medical
records for specific health events. REGARDS reviewed
death certificates, medical records, and interviewed
proxies to discern whether a participant died and the
causes of the death. Further details of REGARDS study
methods are described elsewhere [14].
While the objective of REGARDS was to identify and
characterize stroke events, the population of REGARDS
included community-dwelling adults at healthy baseline -
not just individuals who had suffered a prior stroke. The
REGARDS-sepsis ancillary study used the infrastructure
of the parent REGARDS study to independently identify
sepsis hospitalizations.
Identification of serious infection and sepsis events
We included all hospitalization events reported over a 10-
year follow-up period ending December 31, 2012. The pri-
mary outcomes of this study were 1) first hospitalization for
a serious infection, and 2) hospitalization for sepsis. Usingthe taxonomy of Angus et al., we identified all hospitaliza-
tions (Emergency Department visits and/or hospital admis-
sion) attributed by participants to a serious infection [1].
Two trained reviewers evaluated information from the cor-
responding medical record, confirming the presence of a
serious infection based upon diagnoses documented in the
Emergency Department or admission physician record.
Discordances were adjudicated among abstractors, with
additional physician review as needed.
Using international consensus definitions, we defined sep-
sis events as hospital admission for a serious infection with
the presence of at least two systemic inflammatory response
syndrome (SIRS) criteria, including heart rate >90 beats/
minute, fever (temperature >38.3 °C or <36 °C), tach-
ypnea (>20 breaths/minute) or PCO2 <32 mmHg, and
leukocytosis (white blood cells >12,000 or <4,000 cells/mm3
or >10 % band forms) [1]. We used vital signs and
laboratory test results for the initial 28 hours of
hospitalization. Because of our focus on community-
acquired (vs. hospital-acquired) sepsis, we did not include
sepsis developing at later points during hospitalization.
We did not include organ dysfunction in the definition of
sepsis. Initial review of 1,349 hospital records indicated
excellent inter-rater agreement for presence of serious
infection (kappa = 0.92) and the presence of sepsis
(kappa = 0.90) upon hospital presentation.
Participant characteristics
Participant demographics included self-reported age, race,
sex, income, education, and geographic location. Health be-
haviors included tobacco and alcohol use. Smoking status in-
cluded current, past and never. We defined alcohol use as
moderate (one drink per day for women or two drinks per
day for men) and heavy alcohol use (>1 drink per day for
women and >2 drinks per day for men), per the National In-
stitute on Alcohol Abuse and Alcoholism classification [15].
Baseline medical conditions included atrial fibrillation,
chronic lung disease, coronary artery disease, deep vein
thrombosis, diabetes, dyslipidemia, hypertension, myocar-
dial infarction, obesity, peripheral artery disease, and stroke.
We defined atrial fibrillation by participant self-report or
baseline electrocardiogram (ECG) evidence of an atrial
fibrillation event. Chronic lung disease was defined as
participants with a history of prescribed pulmonary
medication. Coronary artery disease was classified in
participants with a history of heart disease (self-reported
myocardial infarction (MI), coronary artery bypass graft,
bypass, angioplasty, or stent) or ECG evidence. Diabetes
was defined as a fasting glucose level ≥126 mg/L (or
a glucose level ≥200 mg/L for those not fasting) or the use
of insulin or oral hypoglycemic agents. Dyslipidemia con-
sisted of low-density lipoprotein cholesterol >130 mg/dL,
or use of lipid-lowering medications. Hypertension
included systolic blood pressure ≥140 mm Hg, diastolic
Fig. 1 Flowchart of participants in the Reasons for geographic and racial differences in stroke (REGARDS) study who were included in the analysis
Moore et al. Critical Care  (2015) 19:279 Page 3 of 10blood pressure ≥90 mm Hg, or the reported use of antihy-
pertensive agents. MI in participants was defined by ECG
evidence or self-reports of MI in the participant’s history.
Obesity was defined as body mass index (BMI) ≥30kg/m2
in addition to gender-specific waist circumference [16].
REGARDS did not collect information on pulmonary
conditions such as asthma and chronic obstructive
pulmonary disease. Therefore, we defined participant
use of pulmonary medications as a proxy for chronic
lung disease. Obtained from each participant’s medication
inventory, pulmonary medications included beta-2 adrener-
gic agonists, leukotriene inhibitors, inhaled corticosteroids,
combination inhalers, and other pulmonary medications
such as ipratropium, cromolyn, aminophylline and
theophylline. Other medical conditions such as; deep
vein thrombosis, peripheral artery disease, and stroke
were based upon self-reports.
Determination of biomarkers
Biomarkers examined in this study included serum high-
sensitivity C-reactive protein (hsCRP), urinary albumin-
to-creatinine ratio (ACR), Cystatin C (Cyst-C), and
estimated glomerular filtration rate (eGFR). We estimated
glomerular filtration (eGFR) rate using the Chronic
Kidney Disease Epidemiology collaboration (CKD-EPI)
equation [17]. We dichotomized all biomarkers as abnor-
mal or normal within statistical models. We defined eGFR
<60 ml/min/1.73 m2 as abnormal. Consistent with ourprior study, we defined hsCRP >3.0 mg/dL as abnormal
[18]. We defined Cyst-C measurements above the fourth
quartile of values observed in the REGARDS cohort
(≥1.1 mg/dL) as abnormal. We defined ACR ≥30 mg/g as
abnormal. Further details of REGARDS biomarkers are
defined elsewhere [18–20].
Hospital course
We defined hospital course as information about selected
events during the hospital stay. Hospital course variables in-
cluded infection type, presence of severe sepsis, sequential
organ failure assessment (SOFA) for respiratory, renal hep-
atic, cardiovascular, hematologic, and neurologic systems,
mortality in emergency department sepsis (MEDS) score,
ICU admission, hospital mortality, and long-term mortality.
We defined severe sepsis as the presence of sepsis and organ
dysfunction.
Analysis
We compared racial differences in baseline demographics
and hospital presentation characteristics using the
Chi-square test for categorical characteristics, analysis
of variance (ANOVA) for continuous characteristics
(i.e., age), and the Kruskal-Wallis test for non-parametric
continuous variables (i.e., biomarker levels). To estimate
the relative rates of first infection and first sepsis in black
and white participants, we fit a series of Cox proportional
hazards models with time to first infection and time
Table 1 Baseline characteristics of participants in the Reasons for geographic and racial differences in stroke (REGARDS) study,
stratified by race
Black White P value*
(n = 12,216) (n = 17,474)
Age† 64.2 (9.3) 65.6 (9.5) <0.001
Education (%)
≤ High school 2,429 (19.9) 1,279 (7.3) <0.001
High school graduate 3,401 (27.9) 4,266 (24.4)
Some college 3,237 (26.5) 4,713 (27.0)
College grad or more 3,135 (25.7) 7,207 (41.3)
Income (%)
≤$20 000 3,257 (26.7) 2,086 (11.9) <0.001
$20 000−$34 000 3,223 (26.4) 3,951 (22.6)
$35 000−$74 000 3,100 (25.4) 5,708 (32.7)
$75 000 and Above 1,088 (8.9) 3,609 (20.7)
Refuse 1,548 (12.7) 2,120 (12.1)
Geographic region (%)
Stroke belta 6,261 (51.3) 10,239 (58.6) <0.001
Non-beltb 5,955 (48.8) 7,235 (41.4)
Sex
Male 4,622 (37.8) 8,713 (49.9) <0.001
Female 7,594 (62.2) 8,761 (50.1)
Tobacco use
Never 5,521 (45.4) 7,861 (45.1) <0.001
Past 4,529 (37.3) 7,381 (42.4)
Current 2,107 (17.3) 2,177 (12.5)
Alcohol Use
None 8,610 (72.4) 9,632 (55.9) <0.001
Moderate 3,002 (25.2) 6,689 (38.9)
Heavy 288 (2.4) 889 (5.2)
Baseline medical condition
Atrial fibrillation 921 (7.8) 1,628 (9.5) <0.001
Chronic lung disease 960 (7.9) 1,771 (10.1) <0.001
Coronary artery disease 1,857 (15.5) 3,375 (19.6) <0.001
Deep vein thrombosis 600 (4.9) 955 (5.5) 0.02
Diabetes 3,767 (31.0) 2,936 (16.9) <0.001
Dyslipidemia 6,435 (55.3) 10,526 (62.1) <0.001
Hypertension 8,706 (71.4) 8,840 (50.7) <0.001
Myocardial infarction 1,396 (11.7) 2,323 (13.5) <0.001
Obesity 7,684 (63.0) 8,181 (46.9) <0.001
Peripheral artery disease 293 (2.4) 370 (2.1) 0.1
Stroke 982 (8.1) 914 (5.3) <0.001
Abnormal biomarker levels€♯
C-reactive protein (CRP) 2.9 (1.2–6.5) 1.9 (0.9 4.3) <0.001
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Table 1 Baseline characteristics of participants in the Reasons for geographic and racial differences in stroke (REGARDS) study,
stratified by race (Continued)
Albumin creatinine ratio (ACR) 8.1 (4.7–20.9) 7.2 (4.7–14.4) <0.001
Cystatin C 0.9 (0.8–1.1) 1.0 (0.8–1.1) <0.001
Estimated glomerular filtration rate (eGFR) 91.5 (73.9–106.8) 85.5 (72.2–95.0) <0.001
†Mean (standard deviation). aDefined as the states of Alabama, Arkansas, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, and Tennessee;
bdefined as all other states. *Significance determined using Chi-square test, analysis of variance, or the Kruskal-Wallis test. €Median (IQR). ♯CRP in mg/dL; eGFR
in ml/min/1.73 m2; ACR in mg/g; Cystatin C in mg/dL
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at the time of their event, death, or end of follow up
(31 December 2012). We adjusted the estimates for
participant sociodemographic data, health behaviors,
chronic medical conditions and biomarkers. In a separate
sensitivity analysis, we used the Fine and Gray model to
examine all-cause mortality among all participants as a
potential competing risk for sepsis events [21].
To determine the odds of sepsis among those experiencing
an infection, we fit a multivariable logistic regression model
assessing the association between sepsis and race, limiting
the analysis to those with serious infection. We adjusted the
model for sociodemographic data, health behaviors, chronic
medical conditions, and biomarkers.
Due to the number of missing values for several
variables (income 12.4 %, Cyst-C 6.8 %, CRP 6.4 %,
albumin 4.7 %, creatinine 4.5 %), we performed the
multivariable modeling with multiple imputation using
chained equations (Stata MI suite), pooling regression
coefficient estimates for each model across 10 impu-
tations using Rubin’s rules [22, 23]. We used SAS ver-
sion 9.4 and Stata version 13 for all analyses. We
considered p values ≤0.05 statistically significant.Fig. 2 Kaplan-Meier plot for time to first-infection event, stratified by raceResults
Baseline characteristics
Among 30,239 available participants, 549 participants were
excluded from analysis due to incomplete follow-up time,
corresponding to 29,690 participants (Fig. 1). Among the
29,690 participants included in this analysis, there were
12,216 (41.1 %) black participants and 17,474 (58.9 %)
white participants (Table 1). Black and white participants
had a similar distribution of age, but black participants
were more likely to be female than white participants.
Black participants reported lower education and income.
Tobacco use was similar between races, but black
participants were less likely than white participants to use
alcohol. Black participants were more likely to have a
history of diabetes, hypertension, obesity and stroke. White
participants were more likely to have a history of alcohol
use, atrial fibrillation, chronic lung disease, coronary artery
disease, dyslipidemia, and myocardial infarction.
Rates of serious infection and sepsis
There were 2,600 first-infection events over the observa-
tion period. The incidence of first-infection events was
lower for black participants than those who were white
Table 2 Association between race and first-infection and first-sepsis events
Black vs. white




Model 1a Model 2b Model 3c Model 4d
(95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI)
First-infection
event
White 1721 (5.8) 15.76 (15.65, 15.87) 0.77 (0.71, 0.84) 0.70 (0.64, 0.76) 0.68 (0.63, 0.75) 0.65 (0.59, 0.71) 0.65 (0.59, 0.71)
Black 879 (3.0) 12.10 (11.95, 12.26)
First-sepsis event
White 1015 (3.4) 9.10 (8.96, 9.25) 0.76 (0.69, 0.85) 0.68 (0.61, 0.76) 0.67 (0.60, 0.75) 0.63 (0.56, 0.71) 0.64 (0.57, 0.72)
Black 511 (1.7) 6.93 (6.73, 7.13)
Events, number (%) - Crude odds ratio‡ Model 1a Model 2b Model 3c Model 4d
(95 % CI) (95 % CI) (95 % CI) (95 % CI) (95 % CI)
Sepsis (given first-infection event)
White 918 (53.4) - 1.01 (0.86, 1.19) 0.99 (0.84, 1.18) 0.99 (0.83, 1.17) 1.00 (0.83, 1.19) 1.01 (0.84, 1.21)
Black 471 (53.5) -
aAdjusted for sex, age, and geographic region, education level, and income. bAdjusted for model 1 covariates plus tobacco and alcohol use. cAdjusted for model 2
covariates plus baseline chronic medical conditions. dAdjusted for model 3 covariates plus biomarkers. *Estimated from Cox proportional hazard model.
‡Estimated from logistic regression
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(HR) 0.77; 95 % CI, 0.71, 0.84) (Fig. 2, Table 2). The
observed reduced hazard of first infection among
black participants was more pronounced after adjustment
for demographic data, health behaviors, chronic medical
conditions, and biomarkers (adjusted HR 0.65; 95 % CI,
0.59, 0.71) (Fig. 2, Table 2).
Among study participants there were 1,526 first-sepsis
events over the observation period. The incidence of first-
sepsis events was lower for black participants than white
participants (6.93 vs. 9.10 per 1,000 person-years, HR 0.76;
95 % CI, 0.69, 0.85) (Fig. 3, Table 2). Similar to results for
infection, the association was more pronounced afterFig. 3 Kaplan-Meier plot for time to first sepsis, stratified by raceadjustment for demographics, health behaviors, chronic
medical conditions, and biomarkers (adjusted HR
0.64; 95 % CI, 0.57, 0.72) (Fig. 3, Table 2).
Among the 2,600 first-infection events, 1,389 fulfilled
sepsis criteria. Limited to the first-infection participants,
the odds ratio (OR) for sepsis was similar between races
(OR 1.01; 95 % CI, 0.86, 1.19). This association did
not change after adjustment for confounders (adjusted
OR 1.01; 95 % CI, 0.84, 1.21).
Hospital presentation and course
Within the 2,600 first-infection events, infection types,
severe sepsis frequency, SOFA scores, MEDS scores,
Table 3 Hospital presentation and course for first-infection
events stratified by race
Black White P value*
(n = 879) (n = 1,721)
Infection type (%) 0.06
Lung 364 (41.4) 705 (41.0)
Kidney 168 (19.1) 311 (18.1)
Abdominal 132 (15.0) 338 (19.7)
Skin 117 (13.3) 214 (12.4)
Sepsis 44 (5.0) 71 (4.1)
Other 54 (6.1) 82 (4.8)
Severe sepsis (%) 360 (41.0) 662 (38.5) 0.2
SOFA score** 2 (1-4) 2 (1-3) 0.06
MEDS score*** 3 (3-6) 3 (3-9) 0.2
Admission to ICU (%) 65 (7.4) 133 (7.7) 0.8
Hospital mortality (%) 59 (6.7) 104 (6.0) 0.5
Long-term mortality (%) 227 (25.8) 404 (23.4) 0.2
*Estimated using either the Chi-square or Wilcoxon test. **Sequential organ
failure assessment (SOFA) score, 28 hours, median (IQR). ***Mortality in
Emergency Department sepsis (MEDS) score, median (IQR)
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mortality were similar in black and white participants
(Table 3). Among 1,526 first-sepsis events, black par-
ticipants had higher proportions of severe sepsis and
slightly higher SOFA scores (Table 4). Infection types,
MEDS scores, ICU admission, hospital mortality and
long-term mortality were similar in black and white
participants.Table 4 Hospital presentation and course for first-sepsis events
stratified by race
Black White P value*
(n = 511) (n = 1,015)
Infection type (%)
Lung 235 (46.0) 503 (49.5) 0.04
Kidney 93 (18.2) 167 (16.4)
Abdominal 66 (12.9) 166 (16.3)
Skin 47 (9.2) 76 (7.5)
Sepsis 42 (8.2) 61 (6.0)
Other 28 (5.5) 44 (4.3)
Severe sepsis (%) 393 (76.9) 726 (71.5) 0.02
SOFA score** 2 (1-4) 2 (1-3) 0.04
MEDS score*** 3 (3-6) 3 (3-9) 0.2
Admission to ICU (%) 63 (12.3) 125 (12.3) 1.0
Hospital mortality (%) 53 (10.4) 87 (8.6) 0.3
Long-term mortality (%) 162 (31.7) 296 (29.2) 0.3
*Estimated using either the Chi-square or Wilcoxon test. **Sequential organ
failure assessment (SOFA) score, 28 hours, median (IQR). ***Mortality in
Emergency Department sepsis (MEDS) score, median (IQR)Sensitivity analysis
When accounting for all-cause mortality as a competing
risk, the increased rates of sepsis among white partic-
ipants persisted (adjusted sub-HR 0.66; 95 % CI, 0.57,
0.75) (Fig. 4).
Discussion
Prior epidemiological studies using hospital discharge
data have reported higher incidence of sepsis and severe
sepsis among black patients compared to those who
were white (Table 5) [3–6, 10–13]. However, in this
population-based study of community-dwelling adults
in the REGARDS cohort, we found that black partici-
pants were at lower risk of developing sepsis than
white participants. This contrasting racial disparity ap-
peared to be due to lower rates of hospitalization for a ser-
ious infection. Once hospitalized for a serious infection,
the odds of sepsis were similar in black and white
participants. Among those hospitalized for sepsis,
black participants were slightly more likely have severe
sepsis, but other aspects of the hospital course were
similar between races.
The differences in observed race-sepsis associations
between the current and prior studies could be explained
by differences in the identification of sepsis events. Previous
studies have applied ICD-9 taxonomies of Martin, et al.
and Angus, et al. in order to identify sepsis and severe
sepsis hospitalizations (Table 5) [3–6, 10–13]. This ap-
proach could lead to documentation bias, and research
suggests that the use of discharge diagnoses tends to have
poor sensitivity to detect sepsis [24, 26]. For example, a re-
cent study concluded that ICD-9 discharge diagnoses
were highly specific (94.6 %) but had poor sensitivity
(27.6 %) for detecting community-acquired sepsis events.
[26]. Due to the fact that present-on-admission flags are
not commonly available in discharge datasets used for
research purposes, prior sepsis studies were also unable to
disentangle early community-acquired sepsis from later
hospital-acquired sepsis. Moreover, documentation bias is
plausible if physicians were more likely to record sepsis,
infection and organ dysfunction diagnoses based on the
patient’s race.
In contrast to prior work, our study employed compre-
hensive chart review in the definition of sepsis events. By
using a definition that encompassed laboratory measure-
ments and documentation of an infection, it is plausible
that differences in sepsis detection could be attributable to
hospital or ED practices. Specifically, patterns of initial
diagnostic testing may have varied between black and
white participants based on the site of presentation,
leading to differing rates of sepsis. This assertion is
supported by prior research, which indicates that
black patients receive inferior care, such as lower
quality and intensity of care [27]. Although we were not
Fig. 4 Competing Risks Analysis: Cumulative incidence function and adjusted sub-hazard ratio, stratified by race
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analysis, this is an intriguing area of future research.
Studies performed across a wide range of disciplines
indicate that impaired access to care or healthcare status
causes delayed hospital presentation among African
Americans compared to other races [27–30]. An interesting
question is whether white participants may have had
better access to quality outpatient infection care thanTable 5 Association between sepsis and race as determined in eigh
Authors Data Method for seps
identification
Baine et al., 2001 [10] US Medicare discharge data ICD-9-CM discha
diagnoses
Barnato et al., 2008 [3] Six-state hospital discharge
and US Census data
ICD-9-CM discha
diagnoses




Esper et al., 2006 [11] National representative
sample of discharge data
ICD-9-CM discha
diagnoses
Martin et al., 2003 [5] National representative
sample of discharge data
ICD-9-CM discha
diagnoses





McBean et al., 2001 [12] US Medicare discharge data. ICD-9-CM discha
diagnoses




*Means are provided in parentheses - some studies did not report age ranges. **Co
show significance). RR relative risk IRR incidence rate ratioblack participants, with only those with more serious
illness presenting to the hospital for care. This hypothesis
is tempered by the fact that we observed similar
SOFA and MEDS scores between races. The contrasting
findings between the current and prior studies may
have also occurred if black participants were more
likely than white participants to develop hospital-









rge 1991−1998 65−89 years Septicemia Black men RR 2.44
Black women RR 2.13
rge 2001 All ages (36.1) Severe
sepsis
Black RR 1.44;
95 % CI 1.42, 1.46
rge 2002 ≥18 years Sepsis Black RR 2.28
rge 1979−2003 (60.5) Sepsis Mean annual
black RR 1.90;
95 % CI 1.82, 1.98
rge 1979−2000 (60.8) Sepsis Mean annual
black RR 1.90;
95 % CI 1.81, 2.00
rge 2005 All ages Severe
sepsis
Black IRR 1.67
rge 1986−1997 ≥65 years Septicemia Black RR 1.97
rge 1979−1989 ≥20 years Septicemia Black RR 1.87;
95 % CI 1.35, 2.58
nfidence intervals were not provided by all studies (p values were used to
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infections than their white counterparts, which would
support this hypothesis [6]. Because of our focus on
community-acquired sepsis, we did not examine the later
parts of the hospital course to identify the development of
hospital-acquired sepsis.
Racial disparities are important because they may reflect
differences in biological response, genetics, health behav-
iors, or access to or quality of medical care. Studies of
hepatitis C virus and coronary heart disease have affirmed
the presence of racial disparities due to differences in all of
these domains [31–33]. In the national effort to reduce
sepsis morbidity and mortality, racial differences might
shed light on the pathophysiologic or clinical factors that
influence sepsis outcomes. Some may view our results as
negating the need for scrutinizing racial disparities. On the
contrary, our findings - especially as they contrast with
prior studies - signal the need to more intensely explore
racial differences.
Limitations
REGARDS is a longitudinal study intended to investigate
stroke, and not sepsis outcomes. The current analysis is
not a surveillance study, and thus we may not have
achieved complete ascertainment of all sepsis events.
Recall bias is a limitation, and therefore the number of
sepsis events identified may be underestimates. By
design, the REGARDS cohort includes only African
Americans and white Americans, and thus these results
may not be generalizable to other ethnic groups. REGARDS
oversampled black participants in the southeastern US,
potentially limiting generalizability to other populations.
Selection bias or participation bias are potential limita-
tions of this study. By design, the REGARDS cohort con-
tains individuals over 45 years old only; sepsis rates and
the observed associations may have differed for younger
individuals. Thus, it is possible that black participants
may have experienced more sepsis-related events at
younger ages than white participants, an observation
made in previous research [4]. Participants may have
been less likely to participate in the baseline visit of
study based on work status (i.e., black men were less
likely to participate). This is largely explained by
required blood management visits at baseline during
morning weekdays, which may have alternatively
required missed workdays. However, this is likely an
equal burden for all race-sex strata, but could have been
more prevalent for black men. We identified individuals
who presented to the hospital with sepsis, but did not
include those who acquired sepsis during their
hospitalization. Participants in the REGARDS cohort
could be significantly different from prior studied
populations. However, previous studies investigating
the REGARDS cohort have observed racial differencesconsistent with other cohorts; for example, black par-
ticipants having higher risk of fatal coronary heart
disease than white participants [32].
REGARDS did not have information on vaccination,
so we could not ascertain if racial differences in vaccina-
tions may have resulted in different infection rates. Prior
research suggests that black patients have a higher inci-
dence of infections (e.g., bacteremic pneumonia) than
white patients [34, 35]. Robinson, et al. explained that
the racial disparity could be attributed to lower vac-
cination rates among black patients [35]. Furthermore,
an additional study found that after the introduction
of the pneumococcal vaccine, the disparity between
black and white participants diminished [36].
Conclusion
In conclusion, in the national REGARDS cohort, black
participants were less likely than white participants to
experience infection and sepsis events. However, after
hospitalization for first infection there were no racial
differences in the odds of sepsis. Further efforts should
focus on elucidating the underlying reasons for these
observations, which are in contrast to existing literature.
Key messages
 In the REGARDS cohort, the long-term risk of
community-acquired sepsis is higher in white
participants than in black participants.
 In this study, white participants were more likely
to develop both infection and sepsis.
 Among those with first infections, the odds of sepsis
were not different between black and white
participants.
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